Mats Perman
Overview
Explore the profile of Mats Perman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
15
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Perman M, Johansson K, Holmberg E, Karlsson P
Acta Oncol
. 2024 Apr;
63:240-247.
PMID: 38682458
Background And Purpose: Doses to the coronary arteries in breast cancer (BC) radiotherapy (RT) have been suggested to be a risk predictor of long-term cardiac toxicity after BC treatment. We...
2.
Heyman S, Perman M, Radu C
Acta Oncol
. 2024 Apr;
63:118-124.
PMID: 38587061
Background: Anal squamous cell cancer (ASCC) in early stages (T1-2N0M0) is treated with chemoradiotherapy with a 3-year overall survival (OS) exceeding 90%. In Swedish guidelines, it has been optional to...
3.
Johnsson A, Norman D, Angenete E, Cavalli-Bjorkman N, Lagerback C, Leon O, et al.
Acta Oncol
. 2022 Mar;
61(5):575-582.
PMID: 35274596
Background: Squamous cell cancer of the anus is an uncommon malignancy, usually caused by human papilloma virus (HPV). Chemoradiotherapy (CRT) is the recommended treatment in localized disease with cure rates...
4.
Rizell M, Aberg F, Perman M, Ny L, Sten L, Hashimi F, et al.
Case Rep Oncol
. 2020 Jun;
13(1):478-484.
PMID: 32508620
Combined hepatocellular-cholangiocarcinoma (CHC) is a rare type of primary liver cancer, speculated to arise from hepatic progenitor cells, and with a worse prognosis than hepatocellular carcinoma (HCC). Serum alpha-fetoprotein (AFP)...